6533b7d8fe1ef96bd12698cb

RESEARCH PRODUCT

Effects of endurance exercise on serum concentration of calcitonin gene-related peptide (CGRP): A potential link between exercise intensity and headache

Elisa DaneseCantor TarperiKristina SkroceMatteo GelatiFabian Sanchis-gomarMartina MontagnanaGian Luca SalvagnoFederico SchenaGiuseppe Lippi

subject

AdultMalemedicine.medical_specialtyAnti-calcitonin gene-related peptide agentsCalcitonin Gene-Related PeptideClinical BiochemistryVasodilationCalcitonin gene-related peptideRunning03 medical and health sciences0302 clinical medicineEndurance trainingInternal medicinemedicineHumansExerciseMigraineanti-calcitonin gene-related peptide agents ; headache ; migraine ; neuropeptide ; physical activity ; runningNeurogenic inflammationbusiness.industryPhysical activityBiochemistry (medical)HeadacheVO2 max030229 sport sciencesGeneral MedicineMiddle Agedmedicine.diseaseNeuropeptideEndocrinologyMigraineCalcitoninPhysical EnduranceExercise intensityAnti-calcitonin gene-related peptide agents; Headache; Migraine; Neuropeptide; Physical activity; Runningbusiness030217 neurology & neurosurgery

description

Abstract Background Calcitonin gene-related peptide (CGRP) is a powerful neuropeptide that is strongly involved in headache pain pathogenesis by triggering vasodilation, mast cell degranulation and neurogenic inflammation. This evidence has prompted us to investigate the acute influence of endurance exercise on CGRP concentration in blood. Methods The study population consisted of 48 male amateur runners, who ran a half-marathon distance at 75%–85% of maximal oxygen uptake. Blood was drawn before the run (pre-run) and immediately after each runner ended his trial (post-run). The serum concentration of CGRP was measured with a commercial enzyme-linked immunosorbent assay (ELISA) technique. Results Overall, 22/48 subjects (45.8%) reported suffering from headache, three of whom (6.2%) had an exertional headache, whilst 26/48 (54.2%) subjects did not report at least one headache episode during the previous 6 months (i.e. headache-free). All 48 athletes successfully covered the 21.1 km distance. Serum concentration of CGRP significantly increased by 1.5-fold in the entire group, as well as in the headache-positive and headache-free cohorts. Univariate Spearman’s correlation revealed that post-run variation of serum CGRP was significantly and inversely associated with running time (r = −0.30; p = 0.036). Conclusions The serum concentration of CGRP is significantly enhanced by medium-distance endurance exercise and the post-exercise increase is dependent on running intensity. Accordingly, high-exercise intensity might be directly related to triggering both exertional headache and/or migraine episodes.

10.1515/cclm-2019-1337http://hdl.handle.net/2318/1770487